Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants

Clinical trial NCT00262002 · COMPLETED

Trial details

NCT number: NCT00262002
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prevention of Meningococcal Disease

Start date: 2004-09-01
Primary completion: 2005-07-01
Enrollment: 601

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.